Category Archives: Uncategorized

Journal Watch

Posted on by

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

How Differently Should the FDA Regulate Drugs and Devices?

Posted on by

AMA Journal of Ethics
Volume 23, Number 9: E667-756 Sep 2021
https://journalofethics.ama-assn.org/issue/implantable-material-and-device-regulation

 

Implantable Material and Device Regulation
About 10% of Americans will have a device implanted into their bodies during their lifetimes. Fewer than 0.5% of these devices, however, are likely to have been tested in rigorous clinical trials generally regarded as standard by US regulators. Despite looser regulation of materials and devices than for pharmaceuticals, clinician-investigators and the Food and Drug Administration are obligated to balance patient-subjects’ safety with demand for patients’ timely access to technologies and interventions that might improve or extend their lives. This issue investigates that tension.
From the Editor
Sep 2021
How Differently Should the FDA Regulate Drugs and Devices?
Ariel Wampler, MD
This issue invites clinicians, researchers, device representatives, and patient-safety champions to consider how to exercise sufficient caution without stifling innovation.

Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: A multicenter survey

Posted on by

American Journal of Infection Control
September 2021 Volume 49Issue 9 p1093-1214
http://www.ajicjournal.org/current

 

Major Articles
Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: A multicenter survey
Stefania Dzieciolowska, Denis Hamel, Souleymane Gadio,…Leighanne Parkes, Ève Dubé, Yves Longtin
Published online: April 27, 2021
p1152-1157
Open Access

Childhood Bacille Calmette-Guerin Vaccination and Its Association With Less Severe COVID-19 Pneumonia

Posted on by

American Journal of Preventive Medicine
September 2021 Volume 61Issue 3 p311-464
https://www.ajpmonline.org/current

 

Research Articles
Childhood Bacille Calmette-Guerin Vaccination and Its Association With Less Severe COVID-19 Pneumonia
Fan Chen, Guo X. Chen, Jing Zhou, Yun Xue, Mei X. Wu
Published online: April 12, 2021
e119-e126

Supplement 2 2021 When Dying Really Counts

Posted on by

American Journal of Public Health
July 2021 111(52)
http://ajph.aphapublications.org/toc/ajph/current

 

Supplement 2 2021
When Dying Really Counts
This new fully Open Access supplement issue looks at the urgent need to improve the quality of mortality data and routine surveillance in the context of COVID-19 and beyond. Consequences of inaccuracies in mortality data threaten the mission of public health, while challenges facing the professions of those who encounter and study death are facing unprecedented pressures

Understanding the determinants of COVID-19 vaccination intention and willingness to pay: findings from a population-based survey in Bangladesh

Posted on by

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 04 Sep 2021)

 

Understanding the determinants of COVID-19 vaccination intention and willingness to pay: findings from a population-based survey in Bangladesh
Several coronavirus disease (COVID-19) vaccines have already been authorized and distributed in different countries all over the world, including Bangladesh. Understanding public acceptance of such a novel vac…
Authors: Rajon Banik, Md. Saiful Islam, Mamun Ur Rashid Pranta, Quazi Maksudur Rahman, Mahmudur Rahman, Shahina Pardhan, Robin Driscoll, Sahadat Hossain and Md. Tajuddin Sikder
Citation: BMC Infectious Diseases 2021 21:892
Content type: Research
Published on: 31 August 2021

Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 04 Sep 2021)

 

Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE
In the current COVID-19 pandemic, the world has reached an important milestone where vaccinations are discovered and are proven to be effective against SARS-COV-2 infections. Though vaccines against COVID-19 a…
Authors: Faheem Ahamed, Subhashini Ganesan, Anila James and Walid Abbas Zaher
Citation: BMC Public Health 2021 21:1602
Content type: Research
Published on: 30 August 2021

The genomic history of the Middle East

Posted on by

Cell
Sep 02, 2021 Volume 184 Issue 18 p4597-4840
https://www.cell.com/cell/current

 

Featured Article
The genomic history of the Middle East
Mohamed A. Almarri, Marc Haber, Reem A. Lootah, Pille Hallast, Saeed Al Turki, Hilary C. Martin, Yali Xue, Chris Tyler-Smith
Open Access
A high-coverage resource of physically phased genomes from eight Middle Eastern populations generated via linked-read sequencing provides insights into a genetically understudied region and enables more comprehensive study of population history and the detection of millions of variants common to the Middle East but outside short-read accessibility masks and not previously cataloged. It enhances our understanding of regional ancestry, the spread of languages, the effects of climate change on populations, and the evolutionary history of genetic variants.

Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation

Posted on by

Clinical Pharmacology & Therapeutics
Volume 110, Issue 3 Pages: 519-825 September 2021
https://ascpt.onlinelibrary.wiley.com/toc/15326535/current

 

Perspectives
Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation
Andrea Gaedigk, Scott T. Casey, Michelle Whirl-Carrillo, Neil A. Miller, Teri E. Klein
Pages: 542-545
First Published:06 June 2021
… In this Perspective, we have briefly summarized the more recent origins and advances in the field of biologic pharmacogenetics under the academic discipline of vaccinomics. Although many advances have been made and are slowly being incorporated into how industry and biotechnology develops novel vaccine candidates, much more needs to be done. Interest in personalized applications of vaccines and drugs is evident; as one example, consider the tremendous rise in the demand for direct-to-consumer genetic testing. This interest will further accelerate as genetic-based testing becomes cheaper and offers more in-depth information. For example, our own work with the measles virus has uncovered SNPs in the CD46 and IFI44L genes that are associated with a substantial reduction in neutralizing antibody response to measles vaccine.18 Such findings allow the potential for reverse engineering a vaccine that can overcome such a barrier. Understanding why certain individuals are predisposed to specific AEs and which vaccines have a higher risk of eliciting those AEs will allow healthcare providers to match the right vaccine to the right recipient in order to minimize risks and maximize benefits…

Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network

Posted on by

Clinical Pharmacology & Therapeutics
Volume 110, Issue 3 Pages: 519-825 September 2021
https://ascpt.onlinelibrary.wiley.com/toc/15326535/current

Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network
Kathleen M. Giacomini, Jason H. Karnes, Kristine R. Crews, Andrew A. Monte, William A. Murphy, Akinyemi Oni-Orisan, Laura B. Ramsey, Jun J. Yang, Michelle Whirl-Carrillo

 

Pages: 559-562
First Published:28 July 2021

Advanced Therapies and Regulatory Framework in Different Areas of the Globe: Past, Present, and Future

Posted on by

Clinical Therapeutics
May 2021 Volume 43 Issue 5 p793-916
http://www.clinicaltherapeutics.com/current

 

Reviews
Advanced Therapies and Regulatory Framework in Different Areas of the Globe: Past, Present, and Future
Cleila Pimenta, Vitória Bettiol, Thuany Alencar-Silva,…Robert Pogue, Juliana Lott Carvalho, Maria Sueli Soares Felipe
Published online: April 21, 2021 e103-e138
Abstract
Purpose
The field of human medicine is in a constant state of evolution, developing and incorporating technological advances from diverse scientific fields. In recent years, cellular and gene therapies have come of age, challenging regulatory agencies to define the path for commercial registration. Approval necessarily demands robust evidence for safety and efficacy, but these exigencies must not be such that they render unviable the development and testing of the therapeutic agent. Furthermore, reimbursement strategies are required to guarantee commercial viability of these products, to avoid the risk that they will be removed from the market or become unavailable to most patients through lack of financial resources. To address such challenges, several countries have created strategies to manage advanced therapy products.
Methods
Based on official documents published by regulatory agencies worldwide, this review summarizes the current scenario in the United States, Europe, Brazil, Japan, South Korea, and China in this regard, discussing the harmonized and dissonant aspects of the regulatory framework in different regions of the world and exploring perspectives for the future.
Findings
The technical aspects of advanced therapies are increasingly complex, bringing challenges for high mass commercialization and demanding specific regulation. The regulatory framework of the analyzed regions is mainly recent and discordant, but many harmonizing initiatives were observed.
Implications
The comparative analysis of regulatory frameworks in different parts of the world is informative, as scientists must be aware of the rationale of regulators to assertively develop new technology and products that will be commercialized. The comparative analysis also provides insight into the main dissonances that must be addressed, fostering the harmonization of local regulatory frameworks. Many unanswered questions still lie ahead for the field of advanced therapies, and empirical evidence will be the most effective way to separate hype from hope and to establish the most sustainable mechanisms to regulate and finance such products in each part of the world.

Immunogenicity and safety of a live attenuated varicella vaccine in children 1–12 years of age: A randomized, blinded, controlled, non-inferiority phase 3 clinical trial

Posted on by

Contemporary Clinical Trials
Volume 107 August 2021
https://www.sciencedirect.com/journal/contemporary-clinical-trials/vol/107/suppl/C

 

Research article Open access
Immunogenicity and safety of a live attenuated varicella vaccine in children 1–12 years of age: A randomized, blinded, controlled, non-inferiority phase 3 clinical trial
Feng Jiang, Ruizhi Zhang, Qinghu Guan, Qiuyue Mu, … Shiguang Lei
Article 106489

Allegations of misuse of African DNA in the UK: Will data protection legislation in South Africa be sufficient to prevent a recurrence?

Posted on by

Developing World Bioethics
Volume 21, Issue 3 Pages: 97-148 September 2021
https://onlinelibrary.wiley.com/toc/14718847/current

 

ORIGINAL ARTICLES
Allegations of misuse of African DNA in the UK: Will data protection legislation in South Africa be sufficient to prevent a recurrence?
Keymanthri Moodley, Anita Kleinsmidt
Pages: 125-130
First Published: 07 August 2020

COVID-19: The urgent call for academic research in research ethics

Posted on by

Ethics, Medicine and Public Health
September 2021
https://www.sciencedirect.com/journal/ethics-medicine-and-public-health/vol/18/suppl/C

 

Editorial No access
COVID-19: The urgent call for academic research in research ethics
C. Bommier, H.-C. Stœklé, C. Hervé
Article 100679
Section snippets
Rebuilding the scientific ecosystem
Care has a price, research has a price: this engages ethical tensions with the Hippocratic oath and the archetype of scientific knowledge as a not marketable universal good. On the basis of this observation, the states have agreed worldwide to evaluate their scientists on a quantitative model: number of articles published, number of citations. As funding goes to the researchers with the highest number of articles and citations, this has favored the publication of a large number of articles at
The need to develop university research ethics to foster a climate of scientific integrity
The development of university research in medical ethics has, until now, permitted a thorough reflection on the medical relationship and clinical research in the light of the human sciences and through a multidisciplinary approach. It is time for this reflection to be extended to the field of research integrity: indeed, ethical reflection in research can no longer be satisfied with the opinion of committees, since institutional research misconduct reports are always suspect of impartiality [5].

USoM platform. Proposal for an international and transdisciplinary interactive tool for centralization and anthropological exchange around human remains

Posted on by

Ethics, Medicine and Public Health
September 2021
https://www.sciencedirect.com/journal/ethics-medicine-and-public-health/vol/18/suppl/C

 

Research article Abstract only
USoM platform. Proposal for an international and transdisciplinary interactive tool for centralization and anthropological exchange around human remains
A. Augias, S. Ben Amor, P. Charlier, G. Guerard
Article 100677

Ethical issues in genetics and infectious diseases research: An interdisciplinary expert review

Posted on by

Ethics, Medicine and Public Health
September 2021
https://www.sciencedirect.com/journal/ethics-medicine-and-public-health/vol/18/suppl/C

 

Research article Abstract only
Ethical issues in genetics and infectious diseases research: An interdisciplinary expert review
Alexis Walker, Vence L. Bonham, Angie Boyce, Ellen Wright Clayton, … Jeffrey Kahn
Article 100684
Research in genetics and infectious diseases (ID) presents novel configurations of ethical, legal, and social issues (ELSIs) related to the intersection of genetics with public health regulations and the control of transmissible diseases. Such research includes work both in pathogen genetics and on the ways that human genetics affect responses to ID. This paper identifies and systematizes the unique issues at this intersection, based on an interdisciplinary expert review.

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions

Posted on by

The European Journal of Public Health
SUPPLEMENT – Volume 31, Issue Supplement_1, July 2021
https://academic.oup.com/eurpub/issue/31/Supplement_1

 

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions
Mental illness represents an enormous personal, social and societal burden for European citizens1 calling for the need to expand existing models of mental healthcare delivery. In Europe, the Internet is a key source of health information,2 and technology-enhanced (psychological) interventions such as Internet- and mobile-delivered applications (‘eHealth’3 and ‘m-Health’4) have become increasingly popular and studied. There is already strong evidence of the efficacy of online interventions for the prevention and treatment of several psychological disorders5,6 and meta-analyses show effect sizes similar to face-to-face interventions.7

Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy

Posted on by

Expert Review of Vaccines
Vol 20 (7) 2021
https://www.tandfonline.com/toc/ierv20/current

 

Article
Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy
Gabriella Di Giuseppe, Concetta P. Pelullo, Giorgia Della Polla, Maria V. Montemurro, Francesco Napolitano, Maria Pavia & Italo F. Angelillo
Pages: 881-889
Published online: 25 May 2021

Localisation and local humanitarian action

Posted on by

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/localisation-and-local-humanitarian-action/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Knowledge and acceptance of HPV vaccination and its associated factors among parents of daughters in Addis Ababa, Ethiopia: a community-based cross-sectional study

Posted on by

Infectious Agents and Cancer
http://www.infectagentscancer.com/content
[Accessed 04 Sep 2021]

 

Knowledge and acceptance of HPV vaccination and its associated factors among parents of daughters in Addis Ababa, Ethiopia: a community-based cross-sectional study
Authors: Nebiyu Dereje, Abigia Ashenafi, Anteneh Abera, Efrata Melaku, Kaleb Yirgashewa, Meron Yitna, Sarona Shewaye, Tsedenia Fasil and Yadel Yoseph
Content type: Research Article
3 September 2021

Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemic

Posted on by

International Health
Volume 13, Issue 5, September 2021
https://academic.oup.com/inthealth/issue/13/5

 

REVIEW ARTICLES
Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemic
Jong-Koo Lee, Chris Bullen, Yanis Ben Amor, Simon R Bush, Francesca Colombo …
International Health, Volume 13, Issue 5, September 2021, Pages 399–409, https://doi.org/10.1093/inthealth/ihab022

Programmatic evaluation of a school-based typhoid vaccination campaign: findings of qualitative research

Posted on by

International Journal of Community Medicine and Public Health
Vol 8, No 9 (2021) September 2021
https://www.ijcmph.com/index.php/ijcmph/issue/view/80

 

Original Research Articles
Programmatic evaluation of a school-based typhoid vaccination campaign: findings of qualitative research
Farhana Tabassum, Shanila Nooruddin, Atif Habib, Noshad Ali, Imtiaz Hussain, Alfred Pach, Zahid Memon, Sajid Soofi, Zulfiqar A. Bhutta
DOI: 10.18203/2394-6040.ijcmph20213526

Knowledge and perceptions towards candidate COVID-19 vaccines among practicing physicians of Tamil Nadu: a cross-sectional pilot study

Posted on by

International Journal of Community Medicine and Public Health
Vol 8, No 9 (2021) September 2021
https://www.ijcmph.com/index.php/ijcmph/issue/view/80

 

Knowledge and perceptions towards candidate COVID-19 vaccines among practicing physicians of Tamil Nadu: a cross-sectional pilot study
K. R. S. Sivapriya, A. Keerthana, Balaji Arumugam, R. Nivetha
DOI: 10.18203/2394-6040.ijcmph20213548

COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia

Posted on by

International Journal of Infectious Diseases
August 2021 Volume 109 p1-324
https://www.ijidonline.com/current

 

Coronavirus (COVID-19) Collection
COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia
Jad A. Elharake, Bayan Galal, Saleh A. Alqahtani,…Kaveh Khoshnood, Saad B. Omer, Ziad A. Memish
Published online: July 06, 2021
p286-293

Centralized Reminder/Recall for Human Papillomavirus Vaccination: Findings From Two States—A Randomized Clinical Trial

Posted on by

Journal of Adolescent Health
October 2021 Volume 69 Issue 4 p533-682
https://www.jahonline.org/current

 

Original Articles
Centralized Reminder/Recall for Human Papillomavirus Vaccination: Findings From Two States—A Randomized Clinical Trial
Dennis Gurfinkel, Allison Kempe, Christina Albertin,…Heather Roth, Shivani Arora, Peter Szilagyi
Published online: April 09, 2021
p579-587

Overview of the Issue

Posted on by

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

 

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

Justice in COVID-19 vaccine prioritisation: rethinking the approac

Posted on by

Journal of Medical Ethics
September 2021 – Volume 47 – 9
http://jme.bmj.com/content/current

 

Extended essays
Justice in COVID-19 vaccine prioritisation: rethinking the approach (9 June, 2021) Free
Rosamond Rhodes
Abstract
Policies for the allocation of COVID-19 vaccine were implemented in early 2021 as soon as vaccine became available. Those responsible for the planning and execution of COVID-19 vaccination had to make choices about who received vaccination first while numerous authors offered their own recommendations. This paper provides an account of how such decisions should be made by focusing on the specifics of the situation at hand. In that light, I offer an argument for prioritising those who are likely vectors of the disease and a criticism of the victim-focused priority proposals put forward by the US Centers for Disease Control and Prevention, the National Academies of Sciences, Engineering, and Medicine, the UK National Health Service, and others. I also offer thoughts on how those authors may have gone astray.

Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses

Posted on by

Journal of the Royal Society – Interface
September 2021 Volume 18 Issue 182
https://royalsocietypublishing.org/toc/rsif/current

 

Research articles
Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses
Edward M. Hill and Matt J. Keeling
Published:01 September 2021Article ID:20210214
The swift development of SARS-CoV-2 vaccines has been met with worldwide commendation. However, in the context of an ongoing pandemic there is an interplay between infection and vaccination. While infection can grow exponentially, vaccination rates are …

Optimising SARS-CoV-2 vaccination schedules

Posted on by

The Lancet
Sep 04, 2021 Volume 398 Number 10303 p817-930, e12-e13
https://www.thelancet.com/journals/lancet/issue/current

 

Comment
Optimising SARS-CoV-2 vaccination schedules
Cristobal Belda-Iniesta
… In summary, the question to be answered is whether the data published by Liu and colleagues, in combination with those previously published by Borobia and colleagues,3 are enough evidence to initiate the modification of vaccination schedules. Alternatively, large academic phase 3 clinical trials could explore the protection against severe disease, intensive care unit admission, and SARS-CoV-2 mortality using heterologous schedules, but the time and effort that this work would entail should be carefully balanced against the potential benefits.

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Posted on by

The Lancet
Sep 04, 2021 Volume 398 Number 10303 p817-930, e12-e13
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu, et al. with the Com-COV Study Group

Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021

Posted on by

Nature Human Behaviour
Volume 5 Issue 8, August 2021
https://www.nature.com/nathumbehav/volumes/5/issues/8

 

Article | 22 June 2021 | Open Access
Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021
Using data-driven epidemiological modelling, Yu et al. estimate that, even with increasing vaccine availability, China will have to maintain stringent non-pharmaceutical interventions for at least a year to prevent new widespread outbreaks of COVID-19.
Juan Yang, Valentina Marziano, Hongjie Yu

Fundamentals of Public Health: Population Health and Human Rights

Posted on by

New England Journal of Medicine
September 2, 2021 Vol. 385 No. 10
http://www.nejm.org/toc/nejm/medical-journal

 

Perspective
Fundamentals of Public Health: Population Health and Human Rights J. Frenk and O. Gómez-Dantés
The way a society protects and promotes human rights shapes public policies, determines the distribution of resources and access to services, and ultimately affects population health. Scholarship and action on human rights have been foundational to the public health field.

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Posted on by

New England Journal of Medicine
September 2, 2021 Vol. 385 No. 10
http://www.nejm.org/toc/nejm/medical-journal

 

Original Articles
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile A. Jara and Others
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021

Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 04 Sep 2021]

 

Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021
Abiy Tadesse Angelo, Daniel Shiferaw Alemayehu, Aklilu Mamo Dachew
Research Article | published 03 Sep 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0257109

Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 04 Sep 2021]

 

Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan
Satoshi Sunohara, Toshiaki Asakura, Takashi Kimura, Shun Ozawa, Satoshi Oshima, Daigo Yamauchi, Akiko Tamakoshi
Research Article | published 02 Sep 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0257107

Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection

Posted on by

Science Translational Medicine
Volume 13| Issue 609| 1 Sep 2021
https://www.science.org/toc/stm/current

 

Reports
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
Richard A. Urbanowicz et al.
05 Aug 2021
Open Access
Antibody responses to SARS-CoV-2 variants increase after two doses of BNT162b2 vaccine in both previously infected and naïve individuals.

COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience

Posted on by

Vaccine
Volume 39, Issue 34 Pages 4759-4920 (9 August 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/34

 

Discussion Full text access
COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience
Ala’a Al-Shaikh, Nazeema Muthu, Chinara Aidyralieva, Maria Cristina Profili, Saverio Bellizzi
Pages 4769-4771